Founder & CEO of Royalty Pharma. Quest Diagnostics continues to retain royalty rights to other clinical indications that result from Celera's drug assets, including programs that target histone ...

("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the formation of an international clinical advisory panel ...